GlobeNewswire Inc.·Mar 4·NaMAIA Biotech Raises $30M in Public Offering to Fund Clinical TrialsMAIA Biotechnology closes $30M public offering of 20M shares at $1.50/share, funding clinical trials and operations. MAIApublic offeringcommon stock
GlobeNewswire Inc.··Na